Home » In The News » Activist shareholders ask 9 big pharmas to consider whether ‘excessive’ patenting hurts access Activist shareholders ask 9 big pharmas to consider whether ‘excessive’ patenting hurts access Craig Wanda / 16 February 2023 FiercePharma Craig Wanda Share
